Technical Analysis for VIVO - Meridian Bioscience Inc.

Grade Last Price % Change Price Change
grade D 16.36 -0.85% -0.14
VIVO closed down 0.85 percent on Monday, March 18, 2019, on 89 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Flat Down Down
See historical VIVO trend table...

Date Alert Name Type % Chg
Mar 18 50 DMA Resistance Bearish 0.00%
Mar 18 BB Squeeze Ended Range Expansion 0.00%
Mar 18 Down 3 Days in a Row Weakness 0.00%
Mar 15 Fell Below 50 DMA Bearish -0.85%
Mar 15 MACD Bearish Centerline Cross Bearish -0.85%
Mar 15 Bollinger Band Squeeze Range Contraction -0.85%
Mar 14 50 DMA Support Bullish -1.74%
Mar 14 Spinning Top Other -1.74%
Mar 14 Bollinger Band Squeeze Range Contraction -1.74%
Mar 13 20 DMA Resistance Bearish -2.27%

Older signals for VIVO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Meridian Bioscience, Inc., a life science company, develops, manufactures, sells, and distributes clinical diagnostic test kits primarily for gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company's diagnostic products principally include C. difficile for the detection of gastrointestinal diseases, such as antibiotic-associated diarrhea; Rotavirus and Adenovirus products for pediatric diarrhea detection; H. pylori for the detection of stomach ulcers; EHEC test for the detection of Enterohemorrhagic E. coli infection and Campy for the detection of Campylobacter jejuni; and Group A Strep and Group B Strep tests for the detection of streptococcus bacterial infections. Its diagnostic products are also used in the detection of viral diseases, such as mononucleosis, herpes simplex, chicken pox, and shingles; organ transplant infections; parasitic diseases, including giardiasis, cryptosporidiosis, and lyme; and respiratory diseases, such as pneumonia, valley fever, influenza, and respiratory syncytial virus. The company also offers transport media that store and preserve specimen samples from patient collection to laboratory testing; and bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic companies. In addition, it engages in the contract development and manufacture of proteins and other biologicals under cGMP conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines; and sale and distribution of diagnostic test kits manufactured by third-party vendors. The company markets its products through direct sales force and independent distributors primarily to hospitals, reference laboratories, and research customers in the United States, Asia, Canada, South America, Australia, Europe, Africa, and the Middle East. Meridian Bioscience, Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio.
Medicine Biotechnology Antibodies Influenza Diagnostic Products Diarrhea Respiratory Diseases Gastrointestinal Diseases Viral Diseases Herpes Simplex Pneumonia Shingles Zoonoses Human Orthopneumovirus Waterborne Diseases
Is VIVO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 19.84
52 Week Low 13.75
Average Volume 307,423
200-Day Moving Average 16.3135
50-Day Moving Average 16.557
20-Day Moving Average 16.858
10-Day Moving Average 16.589
Average True Range 0.3421
ADX 15.11
+DI 17.1115
-DI 24.551
Chandelier Exit (Long, 3 ATRs ) 16.3537
Chandelier Exit (Short, 3 ATRs ) 17.2463
Upper Bollinger Band 17.4564
Lower Bollinger Band 16.2596
Percent B (%b) 0.08
BandWidth 7.0993
MACD Line -0.0395
MACD Signal Line 0.0141
MACD Histogram -0.0536
Fundamentals Value
Market Cap 690.45 Million
Num Shares 42.2 Million
EPS 0.50
Price-to-Earnings (P/E) Ratio 32.72
Price-to-Sales 3.13
Price-to-Book 3.70
PEG Ratio 1.29
Dividend 0.50
Dividend Yield 3.06%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.75
Resistance 3 (R3) 16.78 16.68 16.69
Resistance 2 (R2) 16.68 16.58 16.67 16.66
Resistance 1 (R1) 16.52 16.52 16.47 16.49 16.64
Pivot Point 16.42 16.42 16.40 16.41 16.42
Support 1 (S1) 16.26 16.32 16.21 16.23 16.08
Support 2 (S2) 16.16 16.26 16.15 16.06
Support 3 (S3) 16.00 16.16 16.04
Support 4 (S4) 15.97